Double-blind Multicenter Placebo-controlled Study of the Safety and Leukostimulatory Activity of the Preparation 'Panagen' in Patients With Breast Cancer

Trial Profile

Double-blind Multicenter Placebo-controlled Study of the Safety and Leukostimulatory Activity of the Preparation 'Panagen' in Patients With Breast Cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Jan 2015

At a glance

  • Drugs Panagen (Primary) ; Cyclophosphamide; Doxorubicin; Fluorouracil
  • Indications Advanced breast cancer; Early breast cancer
  • Focus Therapeutic Use
  • Sponsors Panagen LLC
  • Most Recent Events

    • 29 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top